Preparing for Your GLP-1 Follow-Up Appointment
A practical agenda for your next semaglutide or tirzepatide follow-up: what to bring, what your clinician checks, and which symptoms cannot wait for the visit.

On this page
The short answer
Prepare for a GLP-1 follow-up by bringing a short written record of symptoms, what you have and have not been able to eat or keep down, any change in daily function, and your specific cost or next-step questions. Your clinician will typically check your weight trend, ask about heart rate and gallbladder or thyroid symptoms, review blood glucose if you have diabetes, and confirm your medication list — bring notes rather than trying to remember everything on the spot.
What needs a call now, not your next scheduled visit
Get emergency care for swelling of the face, mouth, tongue, or throat, trouble breathing, fainting, or a rapid heartbeat — these can signal a serious allergic reaction. 1
| What you notice | Why it cannot wait |
|---|---|
| Severe, persistent abdominal pain, possibly spreading to the back, with or without vomiting | This pattern can indicate pancreatitis. Contact your prescriber or seek emergency care rather than waiting for your next visit. 1 2 |
| Abdominal pain lasting several hours, nausea and vomiting, fever or chills, or yellowing of the skin or eyes | These can signal a gallbladder attack or a blocked bile duct, which NIDDK describes as potentially serious if untreated. 5 |
| A lump or swelling in your neck, hoarseness, difficulty swallowing, or shortness of breath | Both semaglutide and tirzepatide labeling list these as reasons to call your doctor immediately. 1 2 |
| Vomiting or diarrhea you cannot keep up with, dark urine, confusion, fainting, or very little urination | These are dehydration warning signs that can need urgent treatment. 6 |
| A new, sustained racing or pounding heartbeat at rest | Semaglutide's label instructs monitoring heart rate and asks patients to report palpitations or a racing heartbeat at rest; tirzepatide trials recorded a smaller average heart-rate increase, so mention a new, sustained change either way. 3 4 |
This is not a complete list. If you feel seriously unwell, get care rather than trying to match your symptoms to a table first. For the fuller range of digestive side effects, see our GLP-1 side effects guide.
What should I bring to a GLP-1 follow-up appointment?
Bring a short written record rather than relying on memory. A five-minute visit does not leave much room to reconstruct a month of symptoms, meals, and questions on the spot. Use this agenda and fill in only what applies to you:
| Bring this | What to write down |
|---|---|
| Symptoms since your last visit | What happened, when it started, whether it is getting better or worse, and anything that made it easier or harder to manage |
| What you have and have not been able to eat or drink | Any stretch of days with reduced appetite, difficulty keeping food or fluids down, or a change in bowel habits |
| Daily function | What feels easier or harder than before — sleep, energy, work, caregiving — not just a number on a scale |
| Your current medication list | Everything you are taking, including supplements, copied from the label rather than from memory |
| Planned procedures | Any upcoming surgery or procedure requiring sedation, so your clinician can advise on timing 3 4 |
| Cost and coverage questions | What is due at this visit, what your next fill will cost, and whether anything about your coverage has changed — see our GLP-1 cost guide for the questions worth asking |
| Your own top question | The one thing you most want answered before you leave |
Write the list on paper or in a phone note before the appointment, not during it. If a symptom is hard to describe in the moment, a note with a date attached is more useful to your clinician than a memory reconstructed under time pressure.
What does a clinician typically check at a follow-up?
Labeling for both medicines instructs patients to keep every scheduled appointment and laboratory visit so the prescriber can track how your body is responding, not only whether you feel unwell. 1 2 A typical follow-up touches on:
| Area | What it involves |
|---|---|
| Weight and appetite trend | How your weight and appetite have changed since your last visit, in the context of your overall treatment plan |
| Blood glucose, if you have diabetes | Prescribing information calls for monitoring blood glucose before and during treatment, and for considering a lower insulin or sulfonylurea dose to reduce hypoglycemia risk 3 4 |
| Heart rate | Semaglutide's label calls for monitoring heart rate at regular intervals and asking patients to report a racing or pounding heartbeat at rest; tirzepatide trials also recorded an average heart-rate increase, worth mentioning if you notice a change 3 4 |
| Gallbladder and thyroid symptoms | Your clinician may ask directly about upper-abdominal pain, jaundice, or neck swelling, since both medicines carry gallbladder and thyroid-related warnings 3 4 5 |
| Injection technique and sites, if applicable | Confirming you are comfortable with the device and rotating sites correctly |
| Full medication list | Checking for interactions, especially with other drugs that need close monitoring or have a narrow safe dosing range |
None of this replaces your own prescriber's judgment about what your specific visit needs — the list above describes what commonly comes up, not a fixed script.
How often should I expect a follow-up?
Neither the semaglutide nor the tirzepatide label sets one fixed visit schedule; the instruction is to keep whatever appointments your prescriber sets and not to skip the lab work that goes with them. 1 2 Our first 90 days planner lays out common check-in windows if you are early in treatment and want a general sense of pacing.
If a new or worsening symptom comes up between visits, that is a reason to contact your care team before your next scheduled date — not a reason to wait, and not something this planning agenda is meant to postpone. Use the table above to judge whether it is urgent; when in doubt, call.
How do I bring up cost, side effects, or a possible medication change?
A specific description gets a more useful answer than a general one. For a side effect, give the symptom, when it started, whether it is improving, and what you have already tried. For cost, ask directly what this visit and your next fill will charge, and whether anything about your plan or coverage is changing — our cost guide has a fuller list of the numbers worth asking for.
If you are wondering whether a different medicine or formulation might suit you better, that is a reasonable follow-up question to raise — but it is a decision for you and your clinician together, based on your history and response so far, not something to decide from an article or to request without that conversation.
Common questions
Should I skip a follow-up if I feel fine and have not had any side effects?
No. Keep the appointment. Labeling for both medicines instructs patients to keep all appointments with their doctor and the laboratory, because monitoring covers things like heart rate and blood glucose trends that are not something you would necessarily feel. 1 2
What if I cannot make my scheduled appointment?
Reschedule as soon as you can rather than letting it lapse. If a new symptom comes up in the gap, do not wait for the rescheduled date — use the guidance above to judge whether it needs a call now.
Can I ask about switching between semaglutide and tirzepatide at a follow-up?
Yes — a follow-up is exactly the setting for that question. See our semaglutide vs. tirzepatide comparison to prepare what you want to ask, and bring the question to your clinician rather than switching on your own.
References
- Semaglutide Injection — MedlinePlus, U.S. National Library of Medicine
- Tirzepatide Injection — MedlinePlus, U.S. National Library of Medicine
- Wegovy Prescribing Information — Novo Nordisk
- Zepbound Prescribing Information — Eli Lilly
- Symptoms & Causes of Gallstones — National Institute of Diabetes and Digestive and Kidney Diseases
- Dehydration — MedlinePlus, U.S. National Library of Medicine
For your information. This article provides general education and does not replace medical advice or an individual evaluation. Talk to your clinician before starting, changing, or stopping treatment. Compounded medications are not FDA-approved.